Global  

India trials for Russia's 'Sputnik-V' vaccine could start in next few weeks

DNA Tuesday, 22 September 2020
Indian trials of the Sputnik-V vaccine candidate, being developed by Russia`s sovereign wealth fund, will enroll 1,000-2,000 participants and be conducted at multiple government and private hospitals across the country, Deepak Sapra, CEO for API and pharmaceutical services at Dr. Reddy`s, told Reuters.
0
shares
ShareTweetSavePostSend
 

💡 One News Page Knowledge: Other News Mentions

Gam-COVID-Vac Gam-COVID-Vac Viral vector vaccine candidate based on human adenovirus

Russian Sputnik V Covid-19 vaccine to be tested on 100 Indian volunteers

The Russian Sputnik V vaccine against Covid-19 will be tested in India on 100 volunteers, the Indian Central Drugs Standard Control Organisation's Drug..
IndiaTimes
Covid-19 cases dip, PM Modi calls for ‘speedy delivery’ of vaccines [Video]

Covid-19 cases dip, PM Modi calls for ‘speedy delivery’ of vaccines

As coronavirus infections continue to dip for the third consecutive week, Prime Minister Narendra Modi on Saturday called for a speedy delivery of Covid-19 vaccine once they are developed. Charing a high-level meet, the PM called for using the election infrastructure of the country for the speedy delivery of the vaccines. His remarks come on day the country’s drug controller allowed clinical trials of Russia’s Sputnik V vaccine candidate and the Serum Institute of India, which is to manufacture the Oxford vaccine candidate, said that India may get a Covid-19 vaccine by March next year. Top stories in this editorji evening playlist.

Credit: HT Digital Content    Duration: 05:47Published

Dr Reddy's gets DCGI go-ahead to conduct Phase 2/3 human trials of Sputnik V in India

After the Indian drug regulator turned down Dr. Reddy’s Laboratories Ltd’s proposal earlier this month to conduct direct Phase-3 human trials for the Russian..
IndiaTimes
Covid update: N95 mask export allowed; India ranks 4th; festival guidelines [Video]

Covid update: N95 mask export allowed; India ranks 4th; festival guidelines

From the Union government lifting restrictions on the export of N-95/FFP2 face masks, to India ranking fourth in a survey of public perception regarding response to the pandemic - here are the top news updates on the Covid-19 outbreak. The central government released guidelines for gatherings as festival season approaches. The standard operating procedure involves mandatory use of masks, social distancing and CCTVs at event sites to monitor compliance. Event premises are also expected to have isolation rooms in case an infected person is found. The Drugs Controller General of India has asked Dr Reddy's Laboratories to file a revised protocol to conduct Phase 2 and 3 clinical trials of Russian vaccine Sputnik V in the country. Meanwhile, the International Monetary Fund said that the economic downturn caused by the pandemic was not as bad as originally feared, thanks to government spending measures. Watch the full video for the other updates regarding the spread of the Sars-CoV-2 coronavirus.

Credit: HT Digital Content    Duration: 03:14Published

You Might Like


Related videos from verified sources

Brazil vaccine participant dies: What next for trials? | Oneindia News [Video]

Brazil vaccine participant dies: What next for trials? | Oneindia News

A vaccine trial participant for Astrazeneca's Covid-19 candidate vaccine has died in Brazil, but the trials won't stop. Some reports say that the person who died had not received the vaccine shot yet...

Credit: Oneindia     Duration: 01:19Published
'Vaccine trials are being expedited,' says Harsh Vardhan at World Bank Annual Meetings [Video]

'Vaccine trials are being expedited,' says Harsh Vardhan at World Bank Annual Meetings

Health Minister Dr Harsh Vardhan at World Bank Annual Meetings Virtual Event said the private companies with research institutes are expediting trials of vaccine candidates. "To address present and..

Credit: ANI     Duration: 02:10Published
J&J pauses Covid vaccine trial after unexplained illness | Oneindia News [Video]

J&J pauses Covid vaccine trial after unexplained illness | Oneindia News

Johnson and Johnson had to pause its clinical trials for a coronavirus candidate vaccine after a participant developed an unexplained illness. This comes after AstraZeneca's trials for its candidate..

Credit: Oneindia     Duration: 01:16Published

Related news from verified sources

Clinical trials of Sputnik V coronavirus vaccine to begin this month in countries including India: RDIF

The clinical trials of Sputnik V vaccine for coronavirus will be held this month in several countries including India, confirmed Kirill Dmitriev, CEO of the...
IndiaTimes Also reported by •DNA

Russia seeks India's help for Sputnik vaccine Phase-3 trial, production

The Russian government has sought India's help in manufacturing the Sputnik V vaccine and also to conduct Phase-3 trials or bridging studies in the country, a...
Mid-Day Also reported by •Indian ExpressIndiaTimesDNA

Russia to sell 100 million doses of Covid-19 vaccine to India

Russia's sovereign wealth fund said on Wednesday it will supply India's Dr Reddy's Laboratories with 100 million doses of the Sputnik-V vaccine against Covid-19...
IndiaTimes


Tweets about this